Home Carboxes 1675-46-3
1675-46-3,MFCD08549622
Catalog No.:AA001XCD

1675-46-3 | 10H-Phenothiazine, 10-(3-chloropropyl)-2-(trifluoromethyl)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
1 week  
$220.00   $154.00
- +
250mg
95%
1 week  
$371.00   $260.00
- +
1g
95%
1 week  
$1,002.00   $702.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA001XCD
Chemical Name:
10H-Phenothiazine, 10-(3-chloropropyl)-2-(trifluoromethyl)-
CAS Number:
1675-46-3
Molecular Formula:
C16H13ClF3NS
Molecular Weight:
343.7943
MDL Number:
MFCD08549622
SMILES:
ClCCCN1c2cc(ccc2Sc2c1cccc2)C(F)(F)F
NSC Number:
217918
Properties
Computed Properties
 
Complexity:
379  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
22  
Hydrogen Bond Acceptor Count:
5  
Rotatable Bond Count:
3  
XLogP3:
5.7  

Downstream Synthesis Route

[1]Schepartz,Alarma;Cuenoud,Bernard[JournaloftheAmericanChemicalSociety,1990,vol.112,#8,p.3247-3249]

[2]Kang,Seokmin;Lee,JungMoo;Jeon,Borami;Elkamhawy,Ahmed;Paik,Sora;Hong,Jinpyo;Oh,Soo-Jin;Paek,SunHa;Lee,C.Justin;Hassan,AhmedH.E.;Kang,SangSoo;Roh,EunJoo[EuropeanJournalofMedicinalChemistry,2018,vol.151,p.186-198]

[3]Ratouis,R.;Boissier,J.R.[BulletindelaSocieteChimiquedeFrance,1966,p.2963-2965]

[1]Arzneimittel-Forschung/DrugResearch,1971,vol.21,p.808-811

40807-61-2    1675-46-3   
4-phenyl-1-3-(2-trifluoromethyl-phenothiazin-10-yl)-propyl-piperidin-4-ol 

[1]Nakanishi;Tashiro;Munakata;Araki;Tsumagari;Imamura[Journalofmedicinalchemistry,1970,vol.13,#4,p.644-648]

[1]CurrentPatentAssignee:DALIANUNIVERSITYOFTECHNOLOGY-CN104829554,2018,BLocationinpatent:Paragraph0028-0031

[2]Dunn,ElyseA.;Roxburgh,Marina;Larsen,Lesley;Smith,RobinA.J.;McLellan,AlexanderD.;Heikal,Adam;Murphy,MichaelP.;Cook,GregoryM.[BioorganicandMedicinalChemistry,2014,vol.22,#19,p.5320-5328]

[3]CurrentPatentAssignee:ASTRAZENECAPLC-WO2008/27521,2008,A1Locationinpatent:Page/Pagecolumn55

[4]Ratouis,R.;Boissier,J.R.[BulletindelaSocieteChimiquedeFrance,1966,p.2963-2965]

[5]Schepartz,Alarma;Cuenoud,Bernard[JournaloftheAmericanChemicalSociety,1990,vol.112,#8,p.3247-3249]

[6]CurrentPatentAssignee:INCEPTIONORION-WO2013/43744,2013,A2Locationinpatent:Paragraph00113

[7]CurrentPatentAssignee:CAMP4THERAPEUTICSCORPORATIONINC-WO2019/195789,2019,A1Locationinpatent:Paragraph00356;00410;00413

[8]Wang,Yuanjiang;Lv,Zhaodan;Chen,Feihong;Wang,Xing;Gou,Shaohua[JournalofMedicinalChemistry,2021,vol.64,#17,p.12877-12892]

39633-82-4    1675-46-3   
1'-3-(2-trifluoromethyl-phenothiazin-10-yl)-propyl-octahydro-1,4'bipyridinyl-4'-carboxylicacidamide 

[1]Nakanishi;Tashiro;Munakata;Araki;Tsumagari;Imamura[Journalofmedicinalchemistry,1970,vol.13,#4,p.644-648]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1675-46-3 Molecular Formula|1675-46-3 MDL|1675-46-3 SMILES|1675-46-3 10H-Phenothiazine, 10-(3-chloropropyl)-2-(trifluoromethyl)-